The FDA has approved GLP-1 receptor agonists for type 2 diabetes management, with select agents (semaglutide/Wegovy and liraglutide/Saxenda) also approved for chronic weight management in adults with BMI 30 kg/m or 27 kg/m with at least one weight-related comorbidity
Key Functional Ingredients Include: N-Acetyl-L-Carnitine : The ester form of carnitine that supports healthy neurological function, mitochondrial wellness, and acetylcholine production N-Acetyl-L-Carnitine contains no starch, corn, milk, wheat, yeast, sugar, eggs, salt, artificial colors, binders, flavors, preservatives, or fish derivatives
Some peptides act as movers that transport materials into cells
Thus, the clinically therapeutic strategy for T2DM should not only effectively control the patients glucose levels, but also minimize the complications of bone metabolism diseases